Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment
- 1 May 2000
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 24 (4) , 521-533
- https://doi.org/10.1016/s0278-5846(00)00090-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- QuetiapineCNS Drugs, 1998
- 564: Multiple-dose pharmacokinetics of ‘seroquel’ (quetiapine) in schizophrenic men and womenSchizophrenia Research, 1997
- 559: In vitro prediction of potential metabolic drug interactions for seroquelSchizophrenia Research, 1997
- A comparison of quetiapine and chlorpromazine in the treatment of schizophreniaActa Psychiatrica Scandinavica, 1997
- Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placeboBiological Psychiatry, 1997
- Quetiapine (‘Seroquel’); an effective and well-tolerated atypical antipsychoticInternational Journal of Psychiatry in Clinical Practice, 1997
- Quantifying Hepatic Function in the Presence of Liver Disease with Phenazone (Antipyrine) and its MetabolitesClinical Pharmacokinetics, 1991
- Effects of organ failure and therapy on drug metabolismCurrent Opinion In Anesthesiology, 1990